The changing dynamics of pharma outsourcing in Asia:

Are you readjusting your sights?

The dynamics of pharma outsourcing and location decisions in Asia are changing. Cost reduction is being augmented and companies need to set their strategic sights on a future world. This new report from PwC highlights the dramatic change and development in pharmaceutical outsourcing in Asia.

The report, The changing dynamics of pharma outsourcing in Asia , covers three significant developments- the trend towards high end innovation, rapid expansion of clinical trials in Asia, and a scaling up of pharma manufacturing in Asia.

Key highlights:

  • strategic context of outsourcing and location decision in Asia
  • moving up the value chain and expansion of clinical trials: the changing nature of pharma outsourcing in Asia
  • overview of Asian regions by three key dimensions: cost, risk and market opportunity